We would love to hear your thoughts about our site and services, please take our survey here.
Good Point made to me last night was the Market Cap is £12.61m and the bank Balance £12m, therefore a no brainer for someone who wished to swoop in and buy the company.
Market Cap is completely ajar to the Companys Portfolio and Cash At Bank, so a re-rate will happen as the maths reflect different to market sentiment. Who knows how long before we see some positive news from Vlad and the team. Short Term investors burnt and LTH's left to watch this play out.
GLA
The American market will no doubt lap this up, especially as it will stop huge hospital bills for the insurers, so for me its a no brainer that they have hit the mark with those whom are breathless in the 3/4 marker. With the huge costs in the USA medical market, saving someone hitting a hospital bed.
For India, with all those patients unable to find oxygen, this certainly helps those getting to that stage. For me it was positive medical facts but a flat presentation. Not surprised when you have Professors talking whom are better situated to research.
Human nature to concentrate on the negative and not the positives, this board and others do it time and time again.
At least they targeted Patients with 3/4 Breathlessness who would benefit the most, so not back to a new Trial and already ahead of the Curve.
Market Sentiment doesn't like delays so has dropped from the Webinar as its not as buoyant as previous interviews. But the message is we are on track and targeting the right patients in Phase III and I can imagine those results will be fantastic.
The Long Game
With a little time on my hand I have looked over the RNS and Trial Information and noted a few points that may have been covered but thought id share and see others view: Comments below links
https://clinicaltrials.gov/ct2/show/NCT04385095 - Recruitment Status
: Active, not recruiting
https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-004743-83/GB
:Trial Status: GB - no longer in EU/EEA
E.8.9 Initial estimate of the duration of the trial
E.8.9.1 In the Member State concerned years 0
E.8.9.1 In the Member State concerned months 6
E.8.9.1 In the Member State concerned days 2
E.8.9.2 In all countries concerned by the trial years 1
E.8.9.2 In all countries concerned by the trial months 0
E.8.9.2 In all countries concerned by the trial days 16
Ceo salary on company accounts
https://hemogenyx.com/wp-content/uploads/2020/05/Hemogenyx_2019_Annual_Report_WEB.pdf
I feel that its Pharma world that people are nervous with and yes SNG has proven in P2 Trials it works and P3 are happening. So many Covid plays across many Pharmaceuticals, which people don't have the time to review them all.
My personal view is that news will land soon and RM has don't a great job steering the ship. Others haven't done a great job and the SP is reflective.
RM has already started the Production Process so Supply wont be an issue and for some major trials to take SNG onboard screams volume. Once positive news lands, then it will see the herd effect with people buying on the up.
GLA
A lot of volume today, but to be expected with new ISA allowance available. Price is up and down throughout the day but will see where we finish up.
Well done those who got caught a little for holding and for DYOR, only a matter of time now before Vlad drops the details. Who knows how long but hopefully this week, but nothing surprises me about Hemo now so could be longer.
GLA
Vlad likes to drop news out of the blue but Tuesdays seem to be his favourite, so I'm predicting Tuesday this week for some more noise.
Be nice if a flurry of positive news happens as being here for a year now (not long i know), i wouldnt mind seeing this share rise and attract some positive vibes.
As the 14m shares we’re sold, does this mean a TR1 to tell us who bought them or am i off the mark here?
Good points but consider 2k cost as an average across the world, America has a costly health service and to prevent a hospital visit and again across the world, its a small price.
Im no expert but if a hospital bed is 2k per day for the NHS with all that entails, its cheap.
Sng on magic monday shot up to about 2 quid
Dropped and rose to 2.50 and the vaccine came out and dropped to a £1, but has recovered to 1.70 with phase fully funded from an 80m placement.
Still in and havent left as awaiting for it to double from here
Only started investing at start of lockdown one and hemo and sng have been my big plays. Didnt cash out in August as feel its far too low. Dont mind the long game but we are getting closer to news that could be a game changer.
I couldnt agree more that we will see some big movements in the next few weeks.
Fomo will kick in and the herds will soon be here looking for 10-15% profits ahead of announcements
Vlad has many fingers in many pies and a track record with his team. If eli lilly dont see the opportunity to spend a few pennies, it would be a shame.
RNS always come out of the blue when it comes to Hemo so could land anytime.
GLA invested
Eli is just an appetizer and they have billions to splash in the market and it wouldnt hurt to get a piece of that to push HEMO to Clin Trials quicker.
The SP will no doubt bounce around and those in at 6p and taking 10% profits will miss out when it jumps to August 2020 highs and stays at that level, 10% v's 110% profit sounds more appealing to me.